Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II

The findings in this study indicated that oroxylin A could potentially be utilized in the development of improved metastatic cancer treatments.